In line with the idea that viral infection could contribute to the increase in patients’ survival, certain authors supported the interpretation that LMP1-EBV could induce a more efficient activation of cytotoxic T lymphocytes (CTL) and, thus, engage a more robust antitumoral immune response [39]. This evidence concerns the gene PDLIM7 and viral infectious disease.